Adjuvant radiation therapy and survival for pure tubular breast carcinoma - Experience from the SEER database Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Breast Neoplasms
  • Carcinoma, Ductal, Breast
  • Radiotherapy, Adjuvant
  • Rare Diseases

abstract

  • Since sufficiently powered large scale clinical trials are unlikely, we would recommend that adjuvant radiation be considered in PTCB patients age 65 or younger, although consideration of the small absolute survival benefit is important. Adjuvant radiation can be omitted for patients older than 65.

publication date

  • September 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2011.10.063

PubMed ID

  • 22543207

Additional Document Info

start page

  • 23

end page

  • 9

volume

  • 84

number

  • 1